Safety, efficacy, and feasibility of intranasal insulin for the treatment of mild cognitive impairment and Alzheimer disease Dementia: A randomized clinical trial
However, it is especially remarkable that within the SUMMIT trial, among patients with HFpEF, the dual glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide agonist, tirzepatide, significantly reduces the combined risk of cardiovascular death or the exacerbation of HF
N.HolmgrenA.ContelM.et al (2016)
Further research investigating time-course changes in citrulline concentration following CM supplementation is required to determine the optimal strategy, although the best recommendation at the moment would be 1 h prior to exercise
The MD meds Way Help Me Choose Simplify decisions with tailored guidance, comparing therapies, clarifying benefits, and matching care to your needs
These medications work by improving how the body manages blood sugar, helping to reduce insulin spikes and support better glucose metabolism overall